Encino, CANCT07323784Now EnrollingIRB Ready

Social Anxiety Disorder (SAD) Clinical Trial in Encino, CA

Access cutting-edge social anxiety disorder (sad) treatment through this clinical trial at a research site in Encino. Study-provided care at no cost to qualified participants.

Sponsored by Newleos Therapeutics, Inc.

Quick Self-Assessment

See if you qualify for this Encino location

Preparing your pre-screening questions…

Expert Care in Encino

Access social anxiety disorder (sad) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related social anxiety disorder (sad) treatment provided free

Apply for This Encino Location

Check if you qualify for this social anxiety disorder (sad) clinical trial in Encino, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Encino

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Encino site if eligible
  4. 4Begin participation

About This Social Anxiety Disorder (SAD) Study in Encino

The primary goal of this Phase 2 clinical trial is to determine the effects of a novel V1a receptor antagonist (NTX-1472) in adults with Social Anxiety Disorder (SAD). The main questions this trial aims to answer are: * Is NTX-1472 safe and well tolerated in adults with SAD? * How effectively does NTX-1472 treat adults with SAD? Researchers will compare the effects of NTX-1472 with matching placebo (a look-alike capsule that contains no drug). Participants will: * Take NTX-1472 or matching placebo every day for 8 weeks * Visit the clinic 6 times over the course of 14 weeks for checkups and tests

Sponsor: Newleos Therapeutics, Inc.

Who Can Participate

Inclusion Criteria

Has provided written informed consent for the study and is willing to comply with all requirements of the protocol
English speaker
Male or female, ≥18 and ≤65 years of age
Current diagnosis of generalized Social Anxiety Disorder (SAD) as defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM 5) and confirmed by the Structured Clinical Interview for DSM-5 (SCID-5-CT).
Clinician-administered Liebowitz Social Anxiety Score (LSAS) total score ≥70 at Screening
Clinician-rated Hamilton Depression Rating Scale (HDRS 17) (17 items) total score \<16 at Screening
If participant is of childbearing potential, must commit to practicing effective methods of birth control during the study and at least 14 days after the last dose. Key

Exclusion Criteria

Current diagnosis of performance-only SAD as defined by the DSM-5 and confirmed by the SCID-5-CT.
Current diagnosis of any of the following psychiatric condition(s) as defined by the DSM-5 (participants with current generalized anxiety disorder may be included): Attention-deficit/hyperactivity disorder, Autism spectrum disorder, Major depressive disorder, Personality disorder, Post-traumatic stress disorder.
Past or current diagnosis of any of the following psychiatric condition(s), as defined by the DSM-5: Bipolar disorder, Feeding and eating disorder (in adulthood), Obsessive-compulsive disorder, Schizophrenia spectrum or other psychotic disorder, Substance use disorder (within 12 months of Screening).
Receiving daily psychotropics within 4 weeks of Screening
Is at risk for suicidal ideation as per C-SSRS
Has moderate or severe hepatic impairment
Has severe renal impairment
Women who are pregnant or women who are currently breastfeeding unless they are willing to stop breastfeeding for the duration of the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Encino?

Yes, this clinical trial (NCT07323784) has an active research site in Encino, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Social Anxiety Disorder (SAD) Treatment Options in Encino, CA

If you're searching for social anxiety disorder (sad) treatment options in Encino, CA, this clinical trial (NCT07323784) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Encino research site is actively enrolling participants for this clinical trial. You'll receive care from experienced social anxiety disorder (sad) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all social anxiety disorder (sad) clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Encino, CA

See all alzheimers disease clinical trials recruiting in Encino — not just this study.

Browse Alzheimers Disease Trials in Encino →

Browse More Trials by Condition

Alzheimers Disease TrialsEssential Tremor TrialsAnxiety TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Encino?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Encino, CA